Select Page

Health Canada Regulatory Requirements for Clinical Trials with Cannabis and Psychedelic-assisted Psychotherapy 

PRESENTED TO: DIA 2024 by BioPharma Services
PRESENTED BY: N.GHARAVI & J. OLDENHOF

PURPOSE

To asses the regulatory requirements and procedures mandated by Health Canada for conducting clinical trials involving cannabis and psychedelic-assisted psychotherapy. 

To access the entire publication and view the full resolution PDF, please complete the form.

Health Canada Regulatory Requirements for Clinical Trials with Cannabis and Psychedelic-assisted Psychotherapy- BioPharma Services Poster_page-0002

Download Publication

BioPharma Services Inc. is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.
You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Popular Posts

View More